Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2023-10-17 00:00:00 ET · period of report 2023-07-25 · accession 0001209191-23-053030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-10-17 | 2023-07-25+ | HRTX | Peraza Lisa | VP, CAO | F - Tax | $1.47 | -15.6K | 53.2K | -23% | -$22.9K |
| DM | 2023-10-17 | 2023-07-25+ | HRTX | Peraza Lisa | VP, CAO | M - OptEx | — | +45.1K | 55.7K | +427% | — |
| DM | 2023-10-17 | 2023-07-25+ | HRTX | Peraza Lisa | VP, CAO | M - OptEx | $0.00 | -45.1K | 7,964 | -85% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-13 | F | D | 860 | $0.72 | 54,822 | D | — | — | (F2) Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. |
| 2 | Common | Common Stock | 2023-07-25 | M | A | 42,631 | — | 67,941 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2023-07-25 | F | D | 14,743 | $1.51 | 53,198 | D | — | — | (F2) Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. |
| 4 | Common | Common Stock | 2023-10-13 | M | A | 552 | — | 53,750 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 5 | Common | Common Stock | 2023-10-13 | M | A | 1,932 | — | 55,682 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 6 | Derivative | Restricted Stock Units | 2023-10-13 | M | D | 552 | $0.00 | 2,208 | D | — · — to — | 552 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). |
| 7 | Derivative | Performance Stock Units | 2023-07-25 | M | D | 42,631 | $0.00 | 0 | D | — · — to — | 42,631 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) On July 25, 2022, the Compensation Committee of the Issuer (the "Committee") granted the Reporting Person Performance Stock Units ("PSUs"), the vesting of which was subject to the achievement of certain corporate performance goals and time-based vesting. On January 18, 2023, the Committee determined that certain performance goals of the PSUs had been achieved. The PSUs were further subject to a time-based vesting schedule. The PSUs vested in full on the first anniversary of the grant date (July 25, 2023). |
| 8 | Derivative | Restricted Stock Units | 2023-10-13 | M | D | 1,932 | $0.00 | 7,964 | D | — · — to — | 1,932 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F5) The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). |